乳腺癌保乳术后放疗:照射体积与乳腺密度对皮肤毒性和水肿的影响
该回顾性队列纳入387例仅接受乳腺放疗、未行化疗且计划数据完整的乳腺癌保乳术后患者,评估PTV与boost体积及参考结构内乳腺腺体密度(HU替代参数)与II级皮肤毒性和水肿的关系。结果显示体积与两类II级毒性显著相关,HU低于−59者II级风险更高;多变量模型仅确认PTV和boost体积为危险因素。
要点
- PTV与boost照射体积增大与II级皮肤毒性及水肿风险升高相关。
- HU低于−59的密度替代指标与II级毒性风险升高相关,但多变量分析未达统计学显著。
- 结合体积与密度因素或有助于改善放疗耐受性,仍需进一步研究。
核心结论
- 乳腺体积、乳腺组织密度与乳腺癌辅助放疗所致毒性之间存在相关性证据。
- 多变量分析在本回顾性队列中未达统计学显著,需进一步研究。
研究设计与样本
- 回顾性队列研究,纳入387例仅接受乳腺放疗、未行化疗且计划数据可完整构建评估的患者。
- 比较发生II级毒性与I级及以下毒性患者之间收集的参数。
主要发现
- 皮肤毒性与水肿形成方面,体积与II级毒性均存在显著相关。
- HU低于−59的患者中该替代标志物的II级风险更高。
- 多变量模型确认PTV体积与boost体积为危险因素,但HU低于59不是。
关键数值与推荐
- 评估参数包括照射PTV、boost体积及定义参考结构内测得的乳腺腺体密度(替代参数)。
- HU阈值:低于−59与II级毒性风险升高相关。
临床怎么用
- 放疗计划评估时可关注PTV与boost体积,作为II级皮肤毒性和水肿的风险提示。
- HU低于−59的密度替代指标可提示风险,但多变量结果不显著,不宜单独作为决策依据。
局限性
- 为回顾性队列研究,多变量分析未达统计学显著。
- 样本仅限未接受化疗、计划数据完整的患者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the favorable toxicity profiles of whole breast radiotherapy, there are subgroups that tend to experience high toxicity. This study examines anatomical and physiological characteristics that can predict the induction of toxicity for skin and edema. METHODS: In the present cohort, we examined 387 patients who received only radiation therapy to the breast, did not receive chemotherapy, and whose planning data could be fully constructed for evaluation. Metric parameters of the therapy that correlate directly with physiological/anatomical characteristics, such as the irradiated PTV and the boost volume, were evaluated. We also measured breast gland density in a defined reference structure (surrogate Parameter). We compared the parameters collected between patients who experienced grade II toxicity after therapy and patients who experienced grade I or less toxicity from the therapy. RESULTS: There was a significant correlation between volume and grade II toxicity for both skin toxicity and edema formation. There was also a higher risk of grade II for the surrogate marker in patients with a HU of less than − 59. The multivariable model for the parameters confirms the volume of the PTV and the boost as risk factors, but not the HU of less than 59. CONCLUSION: There is evidence of a correlation between breast volume, the density of breast tissue and the resulting toxicity of adjuvant radiotherapy in breast cancer. Multivariate analyses were not statistically significant in the retrospective cohort study, and further research is required. Taking these factors into account could further improve treatment tolerance.
引用
- Sonnhoff M, Oyur M, Becker JN, et al. Association between radiation volume and breast density for skin toxicity and breast edema after radiotherapy in breast conserving therapy of breast cancer. Radiat Oncol. 2026. PMID: 41904464. doi:10.1186/s13014-026-02833-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。